Invasive Disease Potential of Pneumococcal Serotypes in Children after PCV13 Implementation

57Citations
Citations of this article
28Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

We aimed to assess the invasive disease potential of non-PCV13 serotypes after the implementation of this vaccine. Most non-PCV13 serotypes had low invasive disease potential. Among serotypes with the highest invasive disease potential (12F, 24F, 38, 8, 33F, 22F, and 10A), all but 24F and 38 were included in PCV20.

Cite

CITATION STYLE

APA

Cohen, R., Levy, C., Ouldali, N., Goldrey, M., Béchet, S., Bonacorsi, S., & Varon, E. (2021). Invasive Disease Potential of Pneumococcal Serotypes in Children after PCV13 Implementation. Clinical Infectious Diseases, 72(8), 1453–1456. https://doi.org/10.1093/cid/ciaa917

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free